Home > Press > Carl Zeiss Ltd. acquires Imaging Associates Ltd.
Abstract:
UK subsidiary of global optical and optoelectronic group enhances microscope imaging support and application delivery
Carl Zeiss Ltd has agreed to acquire Imaging Associates Ltd. as part of its continuing investment into customer support and service delivery.
Imaging Associates (IMAS) has been supporting digital imaging platforms in research, clinical and industrial environments and distributing the Carl Zeiss materials microscopy range in the UK since 1992. The company, with its offices in Bicester, will be fully integrated within the Carl Zeiss organisation and continue to support customers in the industrial and materials microscopy markets.
The IMAS team will also contribute its expertise in software application development and support of digital imaging platforms across the entire Carl Zeiss microscopy product portfolio and to the rapidly expanding installed product base.
The microscopy product portfolio of Carl Zeiss presents an ideal platform for providing customer-specific solutions. Four new materials microscopy products have been brought to the market recently and will form part of the Carl Zeiss display at MicroScience 2010, which begins on June 28th at London's ExCeL conference and exhibition centre.
####
For more information, please click here
Contacts:
John Waite
Copyright © Carl Zeiss
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Acquisitions/Mergers/Splits
180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020
180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020
Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||